Universitätsklinikum Bonn Institut für Experimentelle Hämatologie und Transfusionsmedizin
171 capabilities
Accredited since June 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Venusberg-Campus 1
Bonn 53127 , Germany
Bonn 53127 , Germany
Accreditation
Active
DAkkS
D-ML-13125-01-00
Provides clinical laboratory services spanning clinical chemistry, immunology, molecular human genetics, microbiology, virology, and transfusion medicine, with capabilities in real-time PCR molecular analysis, high-performance liquid chromatography detection, and aggregometry testing.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13125-01-00
Status
ActiveSince
20 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (171)
| Standard Reference | Description | Category |
|---|---|---|
| (IgG / IgM) | Cardiolipin-Antikörper (IgG/IgM) | Biocompatibility (ISO 10993) |
| Anti körper | Thrombozytäre Antikörper | Biocompatibility (ISO 10993) |
| Rhesus-Untergruppen | Rhesus-Untergruppen | Biological / Microbiological |
| (Apixaban) | (Apixaban) | Clinical Chemistry |
| (Edoxaban) | (Edoxaban) | Clinical Chemistry |
| (Fondaparinux) | Anti-Faktor-Xa-Aktivität (Fondaparinux) | Clinical Chemistry |
| (PAP) | Prostata Phosphatase (PAP) | Clinical Chemistry |
| (Rivaroxaban) | (Rivaroxaban) | Clinical Chemistry |
| (VWF:Ac) | (VWF:CB) | Clinical Chemistry |
| (aPTT) | Thromboplastinzeit (aPTT) | Clinical Chemistry |
| APC - Resistenz | APC-Resistenz | Clinical Chemistry |
| Alpha-2-Anti-Plasmin-Aktivität | Alpha-2-Anti-Plasmin-Aktivität | Clinical Chemistry |
| Anti-Thrombin-Aktivität | Antithrombin-Aktivität | Clinical Chemistry |
| Antithrombin-Antigen | Antithrombin-Antigen | Clinical Chemistry |
| Chromogen | Faktor IX chromogen | Clinical Chemistry |
| Collagen-binding-assay | Collagen-binding-assay | Clinical Chemistry |
| Cystein | Homocystein | Clinical Chemistry |
| D-Dimer-Konzentration | D-Dimer-Konzentration | Clinical Chemistry |
| Direkte Faktor-Xa-Inhibitoren | Direkte Faktor-Xa-Inhibitoren | Clinical Chemistry |
| Emicizumab | Emicizumab | Clinical Chemistry |
| Faktor II - Aktivität | Faktor II-Aktivität | Clinical Chemistry |
| Faktor IX Hemmkörper | Faktor IX-Hemmkörper | Clinical Chemistry |
| Faktor V - Aktivität | Faktor V-Aktivität | Clinical Chemistry |
| Faktor VII - Aktivität | Faktor VII-Aktivität | Clinical Chemistry |
| Faktor VIII Hemmkörper | Faktor VIII Hemmkörper | Clinical Chemistry |
| Faktor X - Aktivität | Faktor X-Aktivität | Clinical Chemistry |
| Faktor XI - Aktivität | Faktor XI-Aktivität | Clinical Chemistry |
| Faktor XII - Aktivität | Faktor XII-Aktivität | Clinical Chemistry |
| Faktor XIII - Aktivität | Faktor XIII-Aktivität | Clinical Chemistry |
| Faktor XIII Antigen | Faktor XIII Antigen | Clinical Chemistry |
| Faktor-VIII Clotting "Na" | Faktor-VIII Clotting "Na" | Clinical Chemistry |
| Fibrinogen -Antigen | Fibrinogen Antigen | Clinical Chemistry |
| Fibrinogenaktivität | Fibrinogenaktivität | Clinical Chemistry |
| Gerinnungsfaktor VIII Chromogen | Gerinnungsfaktor VIII Chromogen | Clinical Chemistry |
| HMWK-Aktivität | HMWK-Aktivität | Clinical Chemistry |
| LP (a) | Lipoprotein A Lp(a) | Clinical Chemistry |
| Lupus sensitive APTT | Lupus-sensitive aPTT | Clinical Chemistry |
| PAI Antigen | PAI-Antigen | Clinical Chemistry |
| PAI-Aktivität | PAI-Aktivität | Clinical Chemistry |
| Plasmin-alpha-2-Antiplasminkomplexe | Plasmin-alpha-2-Antiplasminkomplexe | Clinical Chemistry |
| Plasminogen Aktivität | Plasminogen Aktivität | Clinical Chemistry |
| Protein C - Aktivität | Protein C-Aktivität | Clinical Chemistry |
| Protein C Antigen | Protein C Antigen | Clinical Chemistry |
| Prothrombinfragment 1+2 | Prothrombinfragment 1+2 | Clinical Chemistry |
| Präkallikrein-Aktivität | Präkallikrein-Aktivität | Clinical Chemistry |
| Reptilase-Zeit | Reptilasezeit | Clinical Chemistry |
| Thrombelastographie (NATEM) | Thrombelastographie (NATEM) | Clinical Chemistry |
| Thrombin-Antithrombin-Komplexe | Thrombin-Antithrombin-Komplexe | Clinical Chemistry |
| VWF-Aktivität | vWF-Aktivität | Clinical Chemistry |
| t-PA Antigen | t-PA-Antigen | Clinical Chemistry |
| unfraktioniertes Heparin (aPTT) | unfraktioniertes Heparin (aPTT) | Clinical Chemistry |
| vWF-Antigen | vWF-Antigen | Clinical Chemistry |
| Differential Blutbild | Differentialblutbild | Elemental Analysis |
| PROC-Gen | PROC-Gen | Elemental Analysis |
| PROS1-Gen | PROS1-Gen | Elemental Analysis |
| Erythrozytä re Antigene | Erythrozytäre Antigene | Food Safety Testing |
| Erythrozyten (RBC) | Erythrozyten (RBC) | Hematology |
| Granulozyten und Monozyten | Granulozyten und Monozyten | Hematology |
| Hämoglobin (HGB) | Hämoglobin (HGB) | Hematology |
| Hämoglobin (Spendereignung) | Hämoglobin (Spendereignung) | Hematology |
| Kell-System | Kell-System | Hematology |
| Kreuzprobe | Kreuzprobe | Hematology |
| Leukozyten (WBC) | Leukozyten (WBC) | Hematology |
| Leukozytenzahl | Leukozytenzahl | Hematology |
| Reti kulozyten | Retikulozyten | Hematology |
| Thrombinzeit | Thrombinzeit | Hematology |
| Thrombozyten- Aggregation | Thrombozytenaggregation | Hematology |
| (CD42b, CD41a, CD62) | (CD42b, CD41a, CD62) | Immunology / Serology |
| (qualitativ und semi-quantitativ) | (qualitativ und semi-quantitativ) | Immunology / Serology |
| 1/2-go-Antikörper+p24Ag | 1/2-go-Antikörper+p24Ag | Immunology / Serology |
| A-Untergruppe | A-Untergruppe | Immunology / Serology |
| ABD-Identitätstest | ABD-Identitätstest | Immunology / Serology |
| ABO-System und Isoagglutinine | ABO-System und Isoagglutinine | Immunology / Serology |
| ADAMTS-13-Antikörper | ADAMTS-13-Antikörper | Immunology / Serology |
| Alloantikörper | gebundene Auto-/Alloantikörper | Immunology / Serology |
| Anti-Heparin-PF4-Antikörper | Anti-Heparin-PF4-Antikörper | Immunology / Serology |
| Anti-Serin-Prothrombin-Antikörper | Anti-Serin-Prothrombin-Antikörper | Immunology / Serology |
| Antihumanglobulintest | Direkter Antihumanglobulintest | Immunology / Serology |
| Antikörper Differenzierung | Antikörperdifferenzierung | Immunology / Serology |
| Antikörper Suchtest | Antikörpersuchtest | Immunology / Serology |
| Antikörper Titer | Hepatitis-B-Antikörper Titer | Immunology / Serology |
| Blutgruppen-Antigene | Komplette Blutgruppenantigene | Immunology / Serology |
| C1 Esterase-Inhibitor-Aktivität | C1-Esterase-Inhibitor-Aktivität | Immunology / Serology |
| CD34+-Zellzahl | CD34+-Zellzahl | Immunology / Serology |
| Erweiterte Diagnostik für freie | Erweiterte Diagnostik für freie | Immunology / Serology |
| Hepatitis B Surface-Antigen | Hepatitis-B-surface-Antigen | Immunology / Serology |
| Hepatitis C Virus Antikörper | Hepatitis-C-Virus-Antikörper | Immunology / Serology |
| Hepatitis-B-core-Antikörper | Hepatitis-B-core-Antikörper | Immunology / Serology |
| Hämolysine | Hämolysine | Immunology / Serology |
| Immunstatus (CD45, CD3/CD19, CD3/CD4, CD3/CD8, CD3/CD56) | Immunstatus (CD45, CD3/CD19, CD3/CD4, CD3/CD8, CD3/CD56) | Immunology / Serology |
| Komplementaktivierende HLA-Klasse | Komplementaktivierende HLA-Klasse | Immunology / Serology |
| Medikamenten-abhängige | Medikamenten-abhängige | Immunology / Serology |
| Partielle Thromboplastinzeit | Partielle Thromboplastinzeit | Immunology / Serology |
| Phospholipid-Screen IgG/IgM | Phospholipid-Screen IgG/IgM | Immunology / Serology |
| Rhesus-D-Faktor | Rhesus-D-Faktor | Immunology / Serology |
| Thrombozytäre Glykoproteinexpression | Thrombozytäre Glykoproteinexpression | Immunology / Serology |
| (Exone 3 und 7), CYP4F2-Gen | (Exone 3 und 7), CYP4F2-Gen | Molecular Diagnostics / PCR |
| ADAMTS13-Gen | ADAMTS13-Gen | Molecular Diagnostics / PCR |
| Defekt; Gene: P2RY12, P2RY1, | Defekt; Gene: P2RY12, P2RY1, | Molecular Diagnostics / PCR |
| EPCR (PROCR-Gen) | EPCR (PROCR-Gen) | Molecular Diagnostics / PCR |
| Erythrozytäre | Zygosität/Spezielle erythrozytäre | Molecular Diagnostics / PCR |
| F10-Gen | F10-Gen | Molecular Diagnostics / PCR |
| F11-Gen | F11-Gen | Molecular Diagnostics / PCR |
| F12-Gen | F12-Gen | Molecular Diagnostics / PCR |
| F13A und F13B-Gene | F13A und F13B-Gene | Molecular Diagnostics / PCR |
| F2-Gen | F2-Gen | Molecular Diagnostics / PCR |
| F5-Gen | F5-Gen | Molecular Diagnostics / PCR |
| F7-Gen | F7-Gen | Molecular Diagnostics / PCR |
| F8-Gen | F8-Gen | Molecular Diagnostics / PCR |
| F8-Gen, Intron 1 Inversion, Inversion | F8-Gen, Intron 1 Inversion, Inversion | Molecular Diagnostics / PCR |
| F9-Gen | F9-Gen | Molecular Diagnostics / PCR |
| Faktor V-Mutation (G1691A) | Faktor V-Mutation (G1691A) | Molecular Diagnostics / PCR |
| GATA1, VPS33B, VIPAS39, FLI1, MLPH, RAB27A, MYO5A | GATA1, VPS33B, VIPAS39, FLI1, MLPH, RAB27A, MYO5A | Molecular Diagnostics / PCR |
| GGCX-Gen | GGCX-Gen | Molecular Diagnostics / PCR |
| GP5, CD36, TBXA2R, ITGA2B, ITGA2, vWF | GP5, CD36, TBXA2R, ITGA2B, ITGA2, vWF | Molecular Diagnostics / PCR |
| GP9, GP1BA, GP1BB, FERMT3 | GP9, GP1BA, GP1BB, FERMT3 | Molecular Diagnostics / PCR |
| HBV-DNA (Einzeltestung, Pooltestung) | HBV-DNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HCV-RNA (Einzeltestung, Pooltestung) | HCV-RNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HEV-RNA (Einzeltestung, Pooltestung) | HEV-RNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HIV-1/2-RNA (Einzeltestung, Pooltestung) | HIV-1/2-RNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HPA (1,2,3,4,5,6,9 und 15)-Typ | HPA (1,2,3,4,5,6,9 und 15)-Typ | Molecular Diagnostics / PCR |
| KLKB1-Gen | KLKB1-Gen | Molecular Diagnostics / PCR |
| KNG1-Gen | KNG1-Gen | Molecular Diagnostics / PCR |
| LMAN1 und MCFD2-Gene | LMAN1 und MCFD2-Gene | Molecular Diagnostics / PCR |
| MTHFR C677T-Polymorphismus | MTHFR C677T-Polymorphismus | Molecular Diagnostics / PCR |
| NGS Panel 1 - Störungen der | NGS Panel 1 - Störungen der | Molecular Diagnostics / PCR |
| NGS Panel 2 - Thrombozyten-Rezeptor | NGS Panel 2 - Thrombozyten-Rezeptor | Molecular Diagnostics / PCR |
| NGS Panel 3 - Störungen der | NGS Panel 3 - Störungen der | Molecular Diagnostics / PCR |
| NGS Panel 4 - Thrombozytopathien | NGS Panel 4 - Thrombozytopathien | Molecular Diagnostics / PCR |
| NGS Panel 5 - Andere | NGS Panel 5 - Andere | Molecular Diagnostics / PCR |
| NGS Panel 6 - Störungen der | NGS Panel 6 - Störungen der | Molecular Diagnostics / PCR |
| PAI-I (SERPINE1-Gen) | PAI-I (SERPINE1-Gen) | Molecular Diagnostics / PCR |
| Partial, RHCE, RH Dweak/Dparital | Partial, RHCE, RH Dweak/Dparital | Molecular Diagnostics / PCR |
| Plasminogen (PLG-Gen) | Plasminogen (PLG-Gen) | Molecular Diagnostics / PCR |
| Polymorphismus, FV-Leiden | Polymorphismus, FV-Leiden | Molecular Diagnostics / PCR |
| SERPINC1-Gen | SERPINC1-Gen | Molecular Diagnostics / PCR |
| Signaltransduktion; Gene: GNA13, GNAS, PLA2G7, DHCR24, ADRA2A, RASGRP2 | Signaltransduktion; Gene: GNA13, GNAS, PLA2G7, DHCR24, ADRA2A, RASGRP2 | Molecular Diagnostics / PCR |
| THBD-Gen | THBD-Gen | Molecular Diagnostics / PCR |
| Thrombophilie Polymorphismen | Thrombophilie Polymorphismen | Molecular Diagnostics / PCR |
| Thrombozytenadhäsion; Gene: | Thrombozytenadhäsion; Gene: | Molecular Diagnostics / PCR |
| Thrombozytensekretion; Gene: | Thrombozytensekretion; Gene: | Molecular Diagnostics / PCR |
| VKORC1-Gen | VKORC1-Gen | Molecular Diagnostics / PCR |
| VKORC1-Gen Promoter, CYP2C9-Gen | VKORC1-Gen Promoter, CYP2C9-Gen | Molecular Diagnostics / PCR |
| West Nile Virus (Einzeltestung, Pooltestung) | West Nile Virus (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| Zytoskelettdefekten; Gene: | Zytoskelettdefekten; Gene: | Molecular Diagnostics / PCR |
| vWF-Gen | vWF-Gen | Molecular Diagnostics / PCR |
| AB-D | ABD | Other |
| AFP | AFP | Other |
| Anti-Faktor-Xa-Aktivität (NM | Anti-Faktor-Xa-Aktivität (NM | Other |
| Crossmatch (serologische | Crossmatch (serologische | Other |
| Faktor-VIII-Aktivität (Pathromtin | Faktor-VIII-Aktivität (Pathromtin | Other |
| HbF | HbF | Other |
| System) | Verträglichkeitsprobe im HLA-System) | Other |
| Freies Protein-S Antigen | Freies Protein-S Antigen | Spectroscopy (XRF, ICP, AAS) |
| Treponema pallidum Antikörper | Treponema pallidum-Antikörper | Sterility Testing |
| (Actin FS) | Faktor-IX-Aktivität (Actin FS) | Temperature / Pressure |
| (FLAER/CD157) | (FLAER/CD157) | Temperature / Pressure |
| (eingesetzte Agonisten: ADP, Kollagen, Ristocetin, Arachidonsäure) | (eingesetzte Agonisten: ADP, Kollagen, Ristocetin, Arachidonsäure) | Temperature / Pressure |
| Agonisten: ADP, ADP-PGE1, | Agonisten: ADP, ADP-PGE1, | Temperature / Pressure |
| Aktivierte partielle Thromboplastinzeit | Aktivierte partielle Thromboplastinzeit | Temperature / Pressure |
| Erythrozyten (CD59/CD55) | Erythrozyten (CD59/CD55) | Temperature / Pressure |
| Faktor-VIII-Aktivität (Actin | Faktor-VIII-Aktivität (Actin | Temperature / Pressure |
| Heparin induzierter Thrombozytopenie | Heparin induzierter Thrombozytopenie | Temperature / Pressure |
| Hämatokrit (HCT) | Hämatokrit (HCT) | Temperature / Pressure |
| Phosphatidylinositol (GPI) und | Phosphatidylinositol (GPI) und | Temperature / Pressure |
| Thrombozyten (PLT) | Thrombozyten (PLT) | Temperature / Pressure |
| Typ II (HIT II) | Typ II (HIT II) | Temperature / Pressure |
| VWF-Multimere | vWF-Multimere | Temperature / Pressure |
| dRVV-Screen/confirm | dRVV-Screen/confirm | Temperature / Pressure |
| heparininduzierter Antikörper | heparininduzierter Antikörper | Temperature / Pressure |
| verankerten Molekülen auf | verankerten Molekülen auf | Temperature / Pressure |